跳至主要内容
临床试验/ITMCTR2100004792
ITMCTR2100004792招募中1 期

Effects of Shenlingbaizhu powder on the efficacy of chemotherapy and the quality of life of patients with ovarian cancer based on intestinal microecology

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
Female

入选标准

  • 1. The clinicopathological diagnosis was ovarian cancer;
  • 2. Aged 18 to 65 years;
  • 3. The patients whose survival time was more than 3 months were predicted;
  • 4. We plan to stay in our hospital or chemotherapy for more than 3 cycles, including surgical and non-surgical patients. The operation is palliative resection and postoperative metastasis;
  • 5. Understand and willing to participate in this study, voluntarily sign the informed consent for treatment.

排除标准

  • 1. Accompanied by severe infection, high fever, etc;
  • 2. Receiving parenteral nutrition;
  • 3. A large amount of hydrothorax and ascites and severe edema;
  • 4. Patients with cardiovascular and cerebrovascular diseases, liver, kidney, immune and bone marrow dysfunction, psychosis and mental disorders;
  • 5. The cognitive ability of the patients was poor, and they were unable to answer questions or fill in questionnaires.

研究者

发起方
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验